562 related articles for article (PubMed ID: 17367907)
21. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene.
Nong A; McCarver DG; Hines RN; Krishnan K
Toxicol Appl Pharmacol; 2006 Jul; 214(1):78-87. PubMed ID: 16464483
[TBL] [Abstract][Full Text] [Related]
22. Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach.
Yokley K; Tran HT; Pekari K; Rappaport S; Riihimaki V; Rothman N; Waidyanatha S; Schlosser PM
Risk Anal; 2006 Aug; 26(4):925-43. PubMed ID: 16948686
[TBL] [Abstract][Full Text] [Related]
23. Health risk assessment of personal inhalation exposure to volatile organic compounds in Tianjin, China.
Zhou J; You Y; Bai Z; Hu Y; Zhang J; Zhang N
Sci Total Environ; 2011 Jan; 409(3):452-9. PubMed ID: 21078521
[TBL] [Abstract][Full Text] [Related]
24. Use of Markov Chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in US women of childbearing age.
Allen BC; Hack CE; Clewell HJ
Risk Anal; 2007 Aug; 27(4):947-59. PubMed ID: 17958503
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the human kinetic adjustment factor for the health risk assessment of environmental contaminants.
Valcke M; Krishnan K
J Appl Toxicol; 2014 Mar; 34(3):227-40. PubMed ID: 24038072
[TBL] [Abstract][Full Text] [Related]
26. Bayesian estimation of pharmacokinetic and pharmacodynamic parameters in a mode-of-action-based cancer risk assessment for chloroform.
Liao KH; Tan YM; Conolly RB; Borghoff SJ; Gargas ML; Andersen ME; Clewell HJ
Risk Anal; 2007 Dec; 27(6):1535-51. PubMed ID: 18093051
[TBL] [Abstract][Full Text] [Related]
27. A distributed parameter physiologically-based pharmacokinetic model for dermal and inhalation exposure to volatile organic compounds.
Roy A; Weisel CP; Lioy PJ; Georgopoulos PG
Risk Anal; 1996 Apr; 16(2):147-60. PubMed ID: 8638037
[TBL] [Abstract][Full Text] [Related]
28. The impact of hepatic uptake on the pharmacokinetics of organic anions.
Gardiner P; Paine SW
Drug Metab Dispos; 2011 Oct; 39(10):1930-8. PubMed ID: 21778353
[TBL] [Abstract][Full Text] [Related]
29. A generic, cross-chemical predictive PBTK model with multiple entry routes running as application in MS Excel; design of the model and comparison of predictions with experimental results.
Jongeneelen FJ; Berge WF
Ann Occup Hyg; 2011 Oct; 55(8):841-64. PubMed ID: 21998005
[TBL] [Abstract][Full Text] [Related]
30. Joint propagation of variability and imprecision in assessing the risk of groundwater contamination.
Baudrit C; Guyonnet D; Dubois D
J Contam Hydrol; 2007 Aug; 93(1-4):72-84. PubMed ID: 17321003
[TBL] [Abstract][Full Text] [Related]
31. A mechanistic algorithm for predicting blood:air partition coefficients of organic chemicals with the consideration of reversible binding in hemoglobin.
Poulin P; Krishnan K
Toxicol Appl Pharmacol; 1996 Jan; 136(1):131-7. PubMed ID: 8560466
[TBL] [Abstract][Full Text] [Related]
32. Use of a physiologically based model to predict systemic uptake and respiratory elimination of perchloroethylene.
Dallas CE; Muralidhara S; Chen XM; Ramanathan R; Varkonyi P; Gallo JM; Bruckner JV
Toxicol Appl Pharmacol; 1994 Sep; 128(1):60-8. PubMed ID: 8079355
[TBL] [Abstract][Full Text] [Related]
33. Applications of sensitivity analysis to a physiologically based pharmacokinetic model for carbon tetrachloride in rats.
Evans MV; Crank WD; Yang HM; Simmons JE
Toxicol Appl Pharmacol; 1994 Sep; 128(1):36-44. PubMed ID: 8079352
[TBL] [Abstract][Full Text] [Related]
34. Probabilistic dose-response modeling: case study using dichloromethane PBPK model results.
Marino DJ; Starr TB
Regul Toxicol Pharmacol; 2007 Dec; 49(3):285-300. PubMed ID: 17949874
[TBL] [Abstract][Full Text] [Related]
35. Relationships of Indoor, Outdoor, and Personal Air (RIOPA). Part I. Collection methods and descriptive analyses.
Weisel CP; Zhang J; Turpin BJ; Morandi MT; Colome S; Stock TH; Spektor DM; Korn L; Winer AM; Kwon J; Meng QY; Zhang L; Harrington R; Liu W; Reff A; Lee JH; Alimokhtari S; Mohan K; Shendell D; Jones J; Farrar L; Maberti S; Fan T
Res Rep Health Eff Inst; 2005 Nov; (130 Pt 1):1-107; discussion 109-27. PubMed ID: 16454009
[TBL] [Abstract][Full Text] [Related]
36. Assessing human variability in kinetics for exposures to multiple environmental chemicals: a physiologically based pharmacokinetic modeling case study with dichloromethane, benzene, toluene, ethylbenzene, and m-xylene.
Valcke M; Haddad S
J Toxicol Environ Health A; 2015; 78(7):409-31. PubMed ID: 25785556
[TBL] [Abstract][Full Text] [Related]
37. An integrated QSAR-PBPK modelling approach for predicting the inhalation toxicokinetics of mixtures of volatile organic chemicals in the rat.
Price K; Krishnan K
SAR QSAR Environ Res; 2011 Mar; 22(1-2):107-28. PubMed ID: 21391144
[TBL] [Abstract][Full Text] [Related]
38. Modeling the Human Kinetic Adjustment Factor for Inhaled Volatile Organic Chemicals: Whole Population Approach versus Distinct Subpopulation Approach.
Valcke M; Nong A; Krishnan K
J Toxicol; 2012; 2012():404329. PubMed ID: 22523487
[TBL] [Abstract][Full Text] [Related]
39. A system of equations to approximate the pharmacokinetic parameters of lacosamide at steady state from one plasma sample.
Cawello W; Schäfer C
Epilepsy Res; 2014 Aug; 108(6):1068-75. PubMed ID: 24893832
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studies.
Jenner P; Könen-Bergmann M; Schepers C; Haertter S
Clin Ther; 2009 Nov; 31(11):2698-711. PubMed ID: 20110012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
